CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 100 filers reported holding CUE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,586 | -37.0% | 17,646 | 0.0% | 0.00% | – |
| Q2 2023 | $64,408 | +7.3% | 17,646 | +41.9% | 0.00% | – |
| Q1 2022 | $60,000 | -57.7% | 12,437 | -1.1% | 0.00% | – |
| Q4 2021 | $142,000 | -23.7% | 12,581 | -1.4% | 0.00% | – |
| Q3 2021 | $186,000 | -70.1% | 12,763 | -71.0% | 0.00% | – |
| Q1 2020 | $623,000 | -33.5% | 43,944 | -25.5% | 0.00% | – |
| Q4 2019 | $937,000 | – | 58,994 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,545,573 | $3,447,000 | 1.85% |
| P.A.W. CAPITAL CORP | 200,000 | $446,000 | 0.67% |
| SANDERS MORRIS HARRIS LLC | 848,048 | $2,020,000 | 0.50% |
| Monaco Asset Management SAM | 458,851 | $1,023,000 | 0.39% |
| Bleichroeder LP | 555,000 | $1,238,000 | 0.26% |
| APOGEM CAPITAL LLC | 110,614 | $247,000 | 0.25% |
| Slate Path Capital LP | 1,483,619 | $3,308,000 | 0.22% |
| Voss Capital, LLC | 200,000 | $446,000 | 0.13% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,067,000 | 0.11% |
| CARLSON CAPITAL L P | 535,000 | $1,193,000 | 0.09% |